Skip to main content
. 2022 Jan 13;14(2):391. doi: 10.3390/cancers14020391

Figure 2.

Figure 2

The αVβ3 integrin binder shows tumor homing in 786-O RCC tumor-bearing mice. Tumor homing of (A) the IR800-coupled αVβ3 binder conjugate, (B) the non-binding control conjugate, or the (C) carboxylate dye control in 786-O tumor-bearing mice as detected by near-infrared imaging. The color scale shows arbitrary near-infrared fluorescence units as displayed by the Pearl® Imager software. A representative image from each treatment group is shown (n = 3).